Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Filings indexed 603 across all filing types
Latest filing 2023-04-25 Annual Report
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
2022 Annual Report
Annual Report Classification · 100% confidence The document is titled '2022 Annual Report' and contains detailed sections typical of an annual report, including a chairman's statement, business review, management discussion and analysis, directors and senior management, corporate governance report, environmental, social and governance report, directors' report, independent auditor's report, consolidated financial statements, and notes to the financial statements. The document covers the fiscal year ended December 31, 2022, and includes comprehensive financial data and analysis. The length of the document (15,000 characters) and the detailed content confirm it is the full annual report rather than an announcement or summary. Therefore, the appropriate classification is Annual Report (10-K). FY 2022
2023-04-25 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates, quantities, and prices, confirming compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements, earnings data, or management discussions present. The document is a regulatory disclosure about transactions in the company's own shares, specifically share buybacks. Therefore, it fits the category 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement but a full disclosure report on share repurchases.
2023-04-25 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares over various dates, including quantities and prices, and confirms compliance with listing rules. The content is focused on reporting share repurchase transactions and changes in issued share capital, with no financial statements or earnings data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not just an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2023-04-24 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, confirming compliance with listing rules. The content is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is a formal notification of share transactions by the company, specifically repurchases of its own shares. This matches the definition of 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement but a substantive disclosure of share repurchase activity.
2023-04-21 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, confirming compliance with listing rules. The content focuses on share repurchase activities and confirmations related to these transactions. There are no financial statements, earnings data, or management discussions present. The document is a regulatory disclosure about share repurchases, fitting the category of a report on transactions in own shares (share buybacks). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a confident classification.
2023-04-20 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, quantities, prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not a report publication announcement since it contains detailed transactional data. The content fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback activities.
2023-04-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.